Does Dr. EVAN CUMPSTON have financial conflicts of interest?

Dr. EVAN CUMPSTON (MD) has received a total of $2,965 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,965 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. EVAN CUMPSTON?

According to CMS Open Payments data, Dr. EVAN CUMPSTON received funding from STRYKER CORPORATION ($2,380), COCHLEAR AMERICAS ($413), and GLAXOSMITHKLINE ($118).

Does Dr. EVAN CUMPSTON receive research grants or speaking fees?

Dr. EVAN CUMPSTON has received $2,965 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. EVAN CUMPSTON

MDReal-Time Hydrated

Specialty: Otolaryngology, Otology & Neurotology

Practice Location: INDIANAPOLIS, IN 46202

NPI Number: 1376905877

LIFETIME INDUSTRY VALUE

$2,965

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. CUMPSTON is a verified Otolaryngology, Otology & Neurotology practitioner based in INDIANAPOLIS, IN.

Between 2021 and 2024, Dr. CUMPSTON had an overall industry promotional and research financial footprint of $2,965 as recorded in the federal CMS Open Payments database.

$2,965 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. CUMPSTON's primary funding source is STRYKER CORPORATION, which accounts for $2,380 (representing 80.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

STRYKER CORPORATION

Rank 1

$2,380

80.3%

COCHLEAR AMERICAS

Rank 2

$413

13.9%

GLAXOSMITHKLINE

Rank 3

$118

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.